Related Experiment Video

Updated: Jun 12, 2026

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

Solutions for disparities for women with heart disease

Kathryn M O'Callaghan1

  • 1Center for Devices and Radiological Health, US Food and Drug Administration, Silver Spring, MD 20993, USA. kathryn.ocallaghan@fda.hhs.gov

Journal of Cardiovascular Translational Research
|June 19, 2010
PubMed

Insights

Cardiovascular disease (CVD) affects women differently than men, impacting diagnosis and treatment. Further research into biological factors is crucial to improve women

Area of Science:

  • Cardiovascular Medicine
  • Translational Research
  • Sex Differences in Health

Background:

  • Cardiovascular disease (CVD) poses a significant global health burden, with observed disparities between sexes in prevalence, incidence, and outcomes.
  • Differences in symptom presentation, diagnostic accuracy, and treatment responses suggest underlying sex-based variations in CVD etiology and pathophysiology.
  • Existing therapies and medical devices may yield worse outcomes for women compared to men, highlighting a critical need for sex-specific research.

Purpose of the Study:

  • To explore the potential sex differences in the causes and biological mechanisms of cardiovascular disease (CVD).
  • To investigate the impact of female-specific life-cycle changes and biological factors on CVD development and progression.
  • To highlight the role of translational research in addressing disparities in CVD care and outcomes for women.

Main Methods:

  • Review of existing literature on sex differences in cardiovascular disease (CVD) prevalence, incidence, and risk factors.
  • Analysis of disparities in diagnostic accuracy, referral rates, and treatment outcomes between men and women.
  • Exploration of potential biological mechanisms, including hormonal, genetic, and chromosomal factors influencing CVD in women.

Main Results:

  • Significant differences exist in CVD presentation, diagnosis, and response to common treatments between sexes.
  • Women experience worse outcomes with certain procedural, pharmaceutical, and medical device therapies compared to men.
  • Biological factors like estrogen, life-cycle stages, and genetics are implicated but require further investigation.

Conclusions:

  • Translational research is essential to elucidate the biological basis of sex differences in cardiovascular disease (CVD).
  • Understanding these differences will enable the development of targeted strategies to improve CVD care and outcomes for women.
  • Continued efforts in clinical trial diversity and awareness campaigns are vital for advancing women's cardiovascular health.

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...